Filing Flows › Clorox (CLX) › Stock forecast & fair value
Clorox (CLX) stock forecast and fair value
Clorox (CLX) trades at $100.27. 16 analysts' median price target is $96.00 (-4%), from $74.00 to $154.00. Across 15 valuation methods the middle fair value is $117.75 (+17%).
Fair value by method
| Method | Low | Point | High | vs price |
|---|---|---|---|---|
| P/E vs peers | $141.07 | $201.12 | $285.46 | +101% |
| P/E vs peers, weighted | $137.60 | $191.28 | $225.20 | +91% |
| P/E vs peers, matched | $88.13 | $140.14 | $232.88 | +40% |
| EV/Sales vs peers | $92.36 | $157.15 | $223.06 | +57% |
| EV/Sales vs peers, weighted | $147.52 | $209.65 | $255.49 | +109% |
| EV/Sales vs peers, matched | $142.76 | $150.22 | $196.48 | +50% |
| Analysts' price targets | $74.00 | $97.75 | $154.00 | -3% |
| Owner earnings capitalized | $97.57 | $117.75 | $148.48 | +17% |
| Shareholder yield (dividends + buybacks) | $132.07 | $159.40 | $200.99 | +59% |
| Tangible book (asset value) | $0.00 | $0.00 | $0.00 | — |
Clorox's latest quarter
Clorox, Q1 FY27: revenue $1.9B (+33% year over year), operating margin 10.9%, net earnings $170M, operating cash flow $143M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for CLX stock?
The median of 16 analysts' 12-month targets is $96.00, -4% from $100.27; the range is $74.00 to $154.00. The average rating is hold.
What is Clorox's fair value?
The fair-value methods on Filing Flows (DCF, Monte Carlo, peer multiples and others) put it between $0.00 and $209.65, with a middle value of $117.75 against a price of $100.27. Each method's assumptions are on the page.
Does Clorox usually beat earnings estimates?
It beat the consensus EPS estimate in 80% of the quarters on record.
Is CLX stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.